Michael Williams, MD, studied medicine at the University of Cincinnati College of Medicine. He completed his residency in Internal Medicine and fellowship in Hematology/Medical Oncology at the University of Virginia (UVA) Health System in Charlottesville, where he joined the faculty in 1986 currently serves as Chief of the Hematology/Oncology Division and Director of Hematologic Malignancies at UVA Cancer Center. He is also the Byrd S. Leavell Professor of Medicine and Professor of Pathology at UVA School of Medicine.
Dr Williams is passionate about the development of novel therapeutic approaches for non-Hodgkin lymphomas, particularly mantle cell lymphoma, as well as chronic lymphocytic leukemia.
He is a member of the Scientific Advisory Boards of the Lymphoma Research Foundation and the European Mantle Cell Lymphoma Network and Chair of the Hematology Subspecialty Board of the American Board of Internal Medicine. Additionally, Dr Williams is a frequent participant in national and international meetings dedicated to education and research in lymphoma and other hematologic malignancies.